Dynamics of Tumor Stem Cells in Cancer Initiation, Therapy, and Resistance
Dynamics of Tumor Stem Cells in Cancer Initiation, Therapy, and Resistance
批准号:
8326199
负责人:
Ross L Levine
金额:
$47.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-24 至 2014-07-31
关键词:
AftercareAntineoplastic AgentsBehaviorBiochemicalBiological AssayBiologyCancer CenterCell CountCell SeparationCellsChronic Myeloid LeukemiaChronic-Phase Myeloid LeukemiaClinicalClinical DataCombined Modality TherapyComplementDasatinibDataDiseaseDisease OutcomeDoseDrug resistanceElementsEvolutionExperimental ModelsFlow CytometryGenerationsGleevecGoalsGrowthHematopoietic stem cellsHumanImatinibInterferon-alphaInterferonsInternationalLeadMalignant NeoplasmsMalignant neoplasm of brainModelingMolecular AnalysisMusMutationMyeloid LeukemiaPatientsPhiladelphiaPhysiologic pulsePopulationResearchResidual TumorsResistanceRiskRoleSTI571ScheduleSeriesSolid NeoplasmSorting - Cell MovementSprycelStagingStem cellsSystemTechniquesTestingTetracyclinesTimeTransgenic ModelTumor Stem CellsTyrosine Kinase Inhibitoradult stem cellanalogbasebcr-abl Fusion Proteinscancer initiationcancer stem cellcancer therapycell behaviorchemotherapyclinical remissiondesignin vivoinhibitor/antagonistkinase inhibitorleukemic stem cellmalignant breast neoplasmmathematical modelmouse modelpreventprogenitorprogramsrandomized trialresearch studyresistance mutationresponseself-renewalstem cell biologytreatment responsetreatment strategytumor progressiontumorigenesistyrosine kinase ABL1
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Human cancers are sustained in their growth by a pathological counterpart of normal
adult stem cells, cancer stem cells. This concept was first described in human myeloid
leukemias and has later been extended to solid tumors such as breast and brain cancer. A
quantitative understanding of cancer stem cells requires a mathematical framework to
describe the dynamics of cancer initiation and progression, the response to treatment, and
the evolution of resistance. In this proposal, we suggest to use mathematical and
experimental techniques to investigate the biology of cancer stem cells. We will derive
mathematical models to investigate the cell of origin of human cancers, the behavior of
cancer stem cells during therapy, and the evolution of resistance to anti-cancer drugs. We
will use chronic myeloid leukemia (CML) treated with ABL tyrosine kinase inhibitors as
a particular example and will validate the predictions of the mathematical models in a
murine model of CML. Our approach will provide a validated quantitative understanding
of cancer stem cells, and allow us to apply mathematical modeling of cancer stem cells to
biologically and clinically important issues including response to targeted therapies and
evolution of drug resistance.
The Specific Aims are
1. To design a mathematical framework of CML stem cells.
2. To validate the predictions derived in Aim 1 in a murine model of CML.
3. To study the dynamics of resistance to anti-cancer therapy.
4. To investigate the cell of origin of CML.
The research program outlined in this proposal will establish a quantitative understanding
of tumor stem cells in cancer initiation, progression, treatment, and resistance and will
provide theoretical frameworks indispensable for the understanding of cancer stem cell
biology and the optimum administration of therapies. We will also test our mathematical
models in an in vivo system, in order to demonstrate the relevance of our mathematical
models to an experimental model. Although outside the scope of this proposal, the
ultimate goal of this research program is to use mathematical models to develop a general
framework for evaluating the role of cancer stem cells in oncogenesis, and to develop
specific therapies which target cancer stem cells for human malignancies.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.jtbi.2009.11.022
发表时间:
2010-03-21
期刊:
JOURNAL OF THEORETICAL BIOLOGY
影响因子:
2
作者:
[Foo, Jasmine, Michor, Franziska]
通讯作者:
Michor, Franziska
DOI:
10.1016/j.tpb.2010.05.001
发表时间:
2010-08
期刊:
THEORETICAL POPULATION BIOLOGY
影响因子:
1.4
作者:
[Durrett, Rick, Foo, Jasmine, Leder, Kevin, Mayberry, John, Michor, Franziska]
通讯作者:
Michor, Franziska
JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response.
恶性细胞和非恶性细胞中的JAK-STAT途径激活有助于MPN的发病机理和治疗反应。
DOI:
10.1158/2159-8290.cd-14-0736
发表时间:
2015-03
期刊:
Cancer discovery
影响因子:
28.2
作者:
[Kleppe M, Kwak M, Koppikar P, Riester M, Keller M, Bastian L, Hricik T, Bhagwat N, McKenney AS, Papalexi E, Abdel-Wahab O, Rampal R, Marubayashi S, Chen JJ, Romanet V, Fridman JS, Bromberg J, Teruya-Feldstein J, Murakami M, Radimerski T, Michor F, Fan R, Levine RL]
通讯作者:
Levine RL
Selection pressure exerted by imatinib therapy leads to disparate outcomes of imatinib discontinuation trials.
伊马替尼治疗施加的选择压力导致伊马替尼停药试验的不同结果。
DOI:
10.3324/haematol.2012.062844
发表时间:
2012
期刊:
Haematologica
影响因子:
10.1
作者:
[Tang,Min, Foo,Jasmine, Gonen,Mithat, Guilhot,Joelle, Mahon,Francois-Xavier, Michor,Franziska]
通讯作者:
Michor,Franziska
Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies.
在连续和脉冲给药策略期间对靶向抗癌疗法的抵抗力的演变。
DOI:
10.1371/journal.pcbi.1000557
发表时间:
2009-11
期刊:
PLoS computational biology
影响因子:
4.3
作者:
[Foo J, Michor F]
通讯作者:
Michor F
共 6 条
Assessing the Interplay Between Inflammatory Signaling and Epigenetic Dysregulation in Age-associated Clonal Hematopoiesis and Leukemia Initiation
-
批准号:10291637
-
项目类别:
-
资助金额:$53.8万
-
财政年份:2021
-
负责人:Ross L Levine
-
依托单位:
Assessing the Interplay Between Inflammatory Signaling and Epigenetic Dysregulation in Age-associated Clonal Hematopoiesis and Leukemia Initiation
-
批准号:10659254
-
项目类别:
-
资助金额:$51.55万
-
财政年份:2021
-
负责人:Ross L Levine
-
依托单位:
Assessing the Interplay Between Inflammatory Signaling and Epigenetic Dysregulation in Age-associated Clonal Hematopoiesis and Leukemia Initiation
-
批准号:10488271
-
项目类别:
-
资助金额:$51.81万
-
财政年份:2021
-
负责人:Ross L Levine
-
依托单位:
Developmental Research Program
-
批准号:10474305
-
项目类别:
-
资助金额:$7.33万
-
财政年份:2021
-
负责人:Ross L Levine
-
依托单位:
Project 1: Increasing therapeutic efficacy in isocitrate dehydrongenase (IDH)–mutant acute myeloid leukemia (AML)
-
批准号:10474275
-
项目类别:
-
资助金额:$36.77万
-
财政年份:2021
-
负责人:Ross L Levine
-
依托单位:
Synergistic role of signaling and epigenetics in leukemic transformation
-
批准号:10323022
-
项目类别:
-
资助金额:$105.6万
-
财政年份:2017
-
负责人:Ross L Levine
-
依托单位:
Synergistic role of signaling and epigenetics in leukemic transformation
-
批准号:10543794
-
项目类别:
-
资助金额:$105.6万
-
财政年份:2017
-
负责人:Ross L Levine
-
依托单位:
Synergistic role of signaling and epigenetics in leukemic transformation
-
批准号:10737736
-
项目类别:
-
资助金额:$106.2万
-
财政年份:2017
-
负责人:Ross L Levine
-
依托单位:
Synergistic role of signaling and epigenetics in leukemic transformation
-
批准号:10078940
-
项目类别:
-
资助金额:$107.76万
-
财政年份:2017
-
负责人:Ross L Levine
-
依托单位:
ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER
-
批准号:9235262
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2014
-
负责人:Ross L Levine
-
依托单位:
ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER
-
批准号:8605643
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2014
-
负责人:Ross L Levine
-
依托单位:
ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER
-
批准号:9031084
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2014
-
负责人:Ross L Levine
-
依托单位:
Molecular Pathogenesis and Therapy of ET and PMF
-
批准号:9185463
-
项目类别:
-
资助金额:$40.71万
-
财政年份:2010
-
负责人:Ross L Levine
-
依托单位:
Molecular Pathogenesis and Therapy of ET and PMF
-
批准号:8403844
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2010
-
负责人:Ross L Levine
-
依托单位:
Molecular Pathogenesis and Therapy of ET and PMF
-
批准号:8208241
-
项目类别:
-
资助金额:$43.23万
-
财政年份:2010
-
负责人:Ross L Levine
-
依托单位:
Molecular Pathogenesis and Therapy of ET and PMF
-
批准号:8586237
-
项目类别:
-
资助金额:$41.93万
-
财政年份:2010
-
负责人:Ross L Levine
-
依托单位:
Molecular Pathogenesis and Therapy of ET and PMF
-
批准号:8097381
-
项目类别:
-
资助金额:$43.23万
-
财政年份:2010
-
负责人:Ross L Levine
-
依托单位:
Dynamics of Tumor Stem Cells in Cancer Initiation, Therapy, and Resistance
-
批准号:8119712
-
项目类别:
-
资助金额:$48.73万
-
财政年份:2008
-
负责人:Ross L Levine
-
依托单位:
High Throughput Screen for JAK2V617F Mutant Selective Inhibitors
-
批准号:7522193
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2008
-
负责人:Ross L Levine
-
依托单位:
Dynamics of Tumor Stem Cells in Cancer Initiation, Therapy, and Resistance
-
批准号:8235208
-
项目类别:
-
资助金额:$46.02万
-
财政年份:2008
-
负责人:Ross L Levine
-
依托单位:
海外基金